Milvue key facts
as of Nov 2026- Developer of a medical imaging platform designed to enhance the reliability and efficiency of radiological diagnosis.
- Milvue is valued at approximately $24.9M as of Nov 2026 (last reported valuation).
- It has raised $19.7M; the latest was Later Stage VC ($10.5M) in Dec 2024.
- Notable investors include La French Tech, Daffourd Invest, EIT Health, French Tech Health20 Program, Guy Frija — 8 tracked in total.
- Status: Privately Held (backing).
Milvue's last reported valuation, Dec 2024. Nothing priced has surfaced since.
Milvue funding rounds
No funding rounds for Milvue are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Milvue valuation
Milvue's last reported valuation was $24.9 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Milvue investors
8 investors are on record for Milvue, including La French Tech, Daffourd Invest, EIT Health and French Tech Health20 Program.
About Milvue
Developer of a medical imaging platform designed to enhance the reliability and efficiency of radiological diagnosis. The company's platform utilizes artificial intelligence for anomaly detection, real-time quantification, pre-reporting, and workflow prioritization, enabling physicians and medical specialists to improve accuracy, streamline processes, and reduce operational time.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2018
- Employees
- 32
- Website
- milvue.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.